Menu Close

Totm share issuance to complete InterBIO acquisition approved

As many people made New Year’s plans last month, executives at some biometric identity firms rushed to move stock plays ahead. Some of the issuances are pro forma but at least one other indicates possible trouble.

Among them were TOTM, International Biometrics, Precise Biometrics, Idex and Fingerprint Cards.

On the perfunctory side, TOTM, a Singaporean maker of ID management and biometric products, announced that it has received the go-ahead to list up to 470,470,000 new shares that will be used to compensate parties involved in its buyout of International Biometrics.

InterBIO, as the company is known, is an investment holding company that controls a government contractor, PT International Biometrics Indonesia. PT licenses face, finger and iris biometrics software from Tech5.

The buyout, announced in October, was assigned an aggregate value of $46 million, or 14 cents per share. About a half-billion consideration and introducer shares are to be issued as a financing tool to close the deal. The Singapore Exchange’s sign-off means the shares can be listed.

Consideration shares can be used as sweeteners, helping to get a deal signed without committing additional money. A Hong Kong company called Precious Glory Enterprises was promised 28,228,200 new shares as a finder’s reward, helping to get the two parties in a room to negotiate an acquisition.

Publicly owned Precise, meanwhile, has increased its number of shares and votes to backup an employee incentive program.

One million series C shares, all owned by the company, were created to hedge the cost of a long-term incentive plan designed to boost performance from 2022 to 2028.

In October, Precise implemented a rights issue of 2.8 million ordinary and 3.9 million ordinary shares, increasing shares and voted by 6.8 million for a total of 46.4 million.

Rights issues can be a sign of trouble. They give current shareholders the right to buy discounted shares but do not obligate them to do so. The move typically is a way to buy cash that is too expensive to raise other ways.

It is an incentive for current investors to put more money into a company, which sounds good, but the object of an equities market is to let money flow more freely to growth opportunities based on market conditions of the moment, not incentives. And, by definition, increasing share numbers reduces their value.

Publicly held Fingerprint Cards, in fact, has reported that its SEK305 million ($29 million) rights share issue announced in October, increased its series B shares by 14.9 million. Votes grew by the same amount.

As of December 30, Fingerprint Cards reported its B shares totaled 416.6 million with the same number of votes.

Together, A- and B-series shares and votes were 424.4 million and 495.3 million, respectively.

In another pro-forma move, Idex last month announced that it had issued the shares it created last year for a private placement.

Private placements are a form of debt. Shares are created expressly for sale to specific buyers. At the end of a contracted period, the buyer – a de facto lender – typically gets repaid the principal and interest. As many people made New Year’s plans last month, executives at some biometric identity firms rushed to move stock plays ahead. Some of the issuances are pro forma but at least one other indicates possible trouble.

Among them were TOTM, International Biometrics, Precise Biometrics, Idex and Fingerprint Cards.

On the perfunctory side, TOTM, a Singaporean maker of ID management and biometric products, announced that it has received the go-ahead to list up to 470,470,000 new shares that will be used to compensate parties involved in its buyout of International Biometrics.

InterBIO, as the company is known, is an investment holding company that controls a government contractor, PT International Biometrics Indonesia. PT licenses face, finger and iris biometrics software from Tech5.

The buyout, announced in October, was assigned an aggregate value of $46 million, or 14 cents per share. About a half-billion consideration and introducer shares are to be issued as a financing tool to close the deal. The Singapore Exchange’s sign-off means the shares can be listed.

Consideration shares can be used as sweeteners, helping to get a deal signed without committing additional money. A Hong Kong company called Precious Glory Enterprises was promised 28,228,200 new shares as a finder’s reward, helping to get the two parties in a room to negotiate an acquisition.

Publicly owned Precise, meanwhile, has increased its number of shares and votes to backup an employee incentive program.

One million series C shares, all owned by the company, were created to hedge the cost of a long-term incentive plan designed to boost performance from 2022 to 2028.

In October, Precise implemented a rights issue of 2.8 million ordinary and 3.9 million ordinary shares, increasing shares and voted by 6.8 million for a total of 46.4 million.

Rights issues can be a sign of trouble. They give current shareholders the right to buy discounted shares but do not obligate them to do so. The move typically is a way to buy cash that is too expensive to raise other ways.

It is an incentive for current investors to put more money into a company, which sounds good, but the object of an equities market is to let money flow more freely to growth opportunities based on market conditions of the moment, not incentives. And, by definition, increasing share numbers reduces their value.

Publicly held Fingerprint Cards, in fact, has reported that its SEK305 million ($29 million) rights share issue announced in October, increased its series B shares by 14.9 million. Votes grew by the same amount.

As of December 30, Fingerprint Cards reported its B shares totaled 416.6 million with the same number of votes.

Together, A- and B-series shares and votes were 424.4 million and 495.3 million, respectively.

In another pro-forma move, Idex last month announced that it had issued the shares it created last year for a private placement.

Private placements are a form of debt. Shares are created expressly for sale to specific buyers. At the end of a contracted period, the buyer – a de facto lender – typically gets repaid the principal and interest.  Read More   

Generated by Feedzy

Disclaimer

Innov8 is owned and operated by Rolling Rock Ventures. The information on this website is for general information purposes only. Any information obtained from this website should be reviewed with appropriate parties if there is any concern about the details reported herein. Innov8 is not responsible for its contents, accuracies, and any inaccuracies. Nothing on this site should be construed as professional advice for any individual or situation. This website includes information and content from external sites that is attributed accordingly and is not the intellectual property of Innov8. All feeds ("RSS Feed") and/or their contents contain material which is derived in whole or in part from material supplied by third parties and is protected by national and international copyright and trademark laws. The Site processes all information automatically using automated software without any human intervention or screening. Therefore, the Site is not responsible for any (part) of this content. The copyright of the feeds', including pictures and graphics, and its content belongs to its author or publisher.  Views and statements expressed in the content do not necessarily reflect those of Innov8 or its staff. Care and due diligence has been taken to maintain the accuracy of the information provided on this website. However, neither Innov8 nor the owners, attorneys, management, editorial team or any writers or employees are responsible for its content, errors or any consequences arising from use of the information provided on this website. The Site may modify, suspend, or discontinue any aspect of the RSS Feed at any time, including, without limitation, the availability of any Site content.  The User agrees that all RSS Feeds and news articles are for personal use only and that the User may not resell, lease, license, assign, redistribute or otherwise transfer any portion of the RSS Feed without attribution to the Site and to its originating author. The Site does not represent or warrant that every action taken with regard to your account and related activities in connection with the RSS Feed, including, without limitation, the Site Content, will be lawful in any particular jurisdiction. It is incumbent upon the user to know the laws that pertain to you in your jurisdiction and act lawfully at all times when using the RSS Feed, including, without limitation, the Site Content.  

Close Bitnami banner
Bitnami